Synopsis
Podcast by Dr. Cush
Episodes
-
![Artificial Intelligence Detection of CPPD on Hand Radiographs]()
Artificial Intelligence Detection of CPPD on Hand Radiographs
15/06/2024 Duration: 12minDr. Antoni Chan interviews Dr. Thomas Hugle about abstract OP0112 presented at Eular 2024 in Vienna, Austria.
-
![Cognitive Function in Older Adults with Lupus]()
Cognitive Function in Older Adults with Lupus
15/06/2024 Duration: 03minDr. Mrinalini Dey discusses abstract POS0730 presented at Eular 2024 in Vienna, Austria.
-
![Has JAK POT Hit the Spot About Infection Risk?]()
Has JAK POT Hit the Spot About Infection Risk?
14/06/2024 Duration: 06minDr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria.
-
![Select your GCA Therapy]()
Select your GCA Therapy
14/06/2024 Duration: 04minDr. David Liew discusses LBA0001 presented at Eular 2024 in Vienna, Austria.
-
![DMARDs and Herpes Zoster Vaccination: To Stop or Not To Stop]()
DMARDs and Herpes Zoster Vaccination: To Stop or Not To Stop
14/06/2024 Duration: 02minDr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.
-
![EULAR 2024 Daily Recap Days 1 2]()
EULAR 2024 Daily Recap Days 1 & 2
14/06/2024 Duration: 41minDr. Jack Cush moderates EULAR 2024 RECAP for days 1 & 2 with Drs. Mrinalini Day and Yuz Yusof in Vienna, Austria. OP0156
-
![EULAR 2024 Daily Recap: Days 1 2]()
EULAR 2024 Daily Recap: Days 1 & 2
14/06/2024 Duration: 41minDr. Jack Cush moderates EULAR 2024 RECAP for days 1 & 2 with Drs. Mrinalini Day and Yuz Yusof in Vienna, Austria.
-
![Has JAK POT Hit the Spot About Infection Risk?]()
Has JAK POT Hit the Spot About Infection Risk?
14/06/2024 Duration: 06minDr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria.
-
![Difficult-to-treat Rheumatoid Arthritis Validation of the EULAR Definition]()
Difficult-to-treat Rheumatoid Arthritis Validation of the EULAR Definition
14/06/2024 Duration: 03minDr. Mrinalini Dey discusses abstract OP0156 presented at Eular 2024 in Vienna, Austria.
-
![DMARDs and Herpes Zoster Vaccination To Stop or Not To Stop]()
DMARDs and Herpes Zoster Vaccination To Stop or Not To Stop
14/06/2024 Duration: 02minDr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.
-
![Does Withdrawing Steroids Increase Flares in SLE?]()
Does Withdrawing Steroids Increase Flares in SLE?
14/06/2024 Duration: 03minDr. Janet Pope reports on abstract OP0180 presented at Eular 2024 in Vienna, Austria.
-
![Weve Got to Talk about CAR T cells]()
We've Got to Talk about CAR T cells
14/06/2024 Duration: 07minDr. Yuz Yusof discusses abstract OP0017 presented at the Eular 2024 meeting in Vienna, Austria.
-
![EULAR 2024 Daily Podcasts Day12]()
EULAR 2024 Daily Podcasts Day1&2
13/06/2024 Duration: 01h19minDo we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib Transition from Psoriasis to PsA: Can we Prevent It? Dr. Aurelie Najm discusses abstract OP0010 presented at Eular 2024 in Vienna, Austria. JAK Inhibitors for New Indications Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria. PsA Treatment: is Earlier Better? Dr. Aurelie Najm discusses abstract OP0184, presented at Eular 2024 in Vienna, Austria. Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter? Dr. Eric Ruderman discusses abstracts OP0046 and POS0058 presented at Eular 2024 in Vienna, Austria. OP0046 Effect on SI joint structural lesions with ixekizumab POS0058
-
![Predicting Palindromic Prognosis]()
Predicting Palindromic Prognosis
13/06/2024 Duration: 02minDr. David Liew discusses abstract OP0127 at Eular 2024 in Vienna, Austria.
-
![A Step Closer to Identifying Phenotypes of RA ILD]()
A Step Closer to Identifying Phenotypes of RA ILD
13/06/2024 Duration: 03minDr. Mrinalini Dey discusses abstract OP0202 presented at Eular 2024 in Vienna, Austria.
-
![Top 3 Messages About JAK Inhibitor Safety]()
Top 3 Messages About JAK Inhibitor Safety
13/06/2024 Duration: 01minDr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.
-
![Pain in RA: Different Drugs for Different Mechanisms]()
Pain in RA: Different Drugs for Different Mechanisms
13/06/2024 Duration: 06minDr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.
-
![Giant Cell Arteritis and Polymyalgia Rheumatica Update]()
Giant Cell Arteritis and Polymyalgia Rheumatica Update
13/06/2024 Duration: 02minDr. Janet Pope discusses abstracts LBA0001, OP0233, OP0261 and POS0280 at Eular 2024 in Vienna, Austria.
-
![JAK Inhibitors for New Indications]()
JAK Inhibitors for New Indications
13/06/2024 Duration: 02minDr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.
-
![Top 3 Messages About JAK Inhibitor Safety]()
Top 3 Messages About JAK Inhibitor Safety
13/06/2024 Duration: 01minDr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.
